Jain Global’s Editas Medicine EDIT Stock Holding History

Jain Global’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-42,186	Closed	-$48.9K	–	1298
2025 Q1	$48.9K	Sell	42,186 -62,630	-60%	-$92.1K	﹤0.01%	1007
2024 Q4	$133K	Buy	+104,816	New	+$267K	﹤0.01%	676

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jain Global's EDIT Position: Q2 2025 in Review

Jain Global sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 42,186 shares — an estimated $48.9K sold.

Jain Global first reported a position in EDIT in Q4 2024 and held it in 2 quarters. The position peaked at $133K in Q4 2024. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

Jain Global reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
Jain Global sold 42,186 Editas Medicine shares in Q2 2025, an estimated $48.9K.
Jain Global first reported a position in Editas Medicine in Q4 2024 and held it in 2 quarters.
Jain Global's Editas Medicine position peaked at $133K in Q4 2024.
193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.